This meta-analysis found that the risk of both hospital and community acquired pneumonia is significantly higher in those on PPI or H2 blockers. This is the strongest evidence to date of the risk elevation of pneumonia in these drugs (adjusted OR range 1.22 to 1.27), which should not be presribed without an definitive indication (abstract)
Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.